Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database
For patients with metastatic prostate cancer that is still responsive to hormone therapy, a complete response after treatment with a drug called apalutamide is associated with a very low risk of progression within 2 years. However, nearly half of patients with an incomplete response to apalutamide will experience progression of their cancer.
Authors
- Raquel Sopeña Sutil (ORCID: https://orcid.org/0000-0003-3646-3341)
- Almudena Cascales (ORCID: https://orcid.org/0000-0002-7215-678X)
- Jesús Muñoz Rodríguez (ORCID: https://orcid.org/0000-0002-3830-6086)
- José Alemán (ORCID: https://orcid.org/0000-0002-9154-4067)
- Juan Gómez Rivas (ORCID: https://orcid.org/0000-0002-0556-3035)
- N. García (ORCID: https://orcid.org/0000-0003-1379-0921)
- Antoni Vilaseca (ORCID: https://orcid.org/0000-0003-0160-620X)
- Marta Román (ORCID: https://orcid.org/0000-0001-9076-8918)
- A. Bonet (ORCID: https://orcid.org/0000-0001-6968-9342)
- M. Backhaus (ORCID: https://orcid.org/0000-0001-6214-784X)
- Estefanía Linares (ORCID: https://orcid.org/0000-0003-4569-9436)
- Kinga Máté (ORCID: https://orcid.org/0000-0001-7791-1759)
- Miguel García Sanz
- Luigi Formisano (ORCID: https://orcid.org/0000-0001-7205-5105)
- Darío Vázquez-Martul Pazos
- Miguel Á. Climent Durán (ORCID: https://orcid.org/0000-0001-7523-0212)
- Pedro de Pablos‐Rodríguez (ORCID: https://orcid.org/0000-0003-2286-9893)
- Meritxell Pérez Márquez
- Á. Zamora Horcajada
- Marc Costa Planells
- Mario Domínguez Esteban
- J.M. De La Morena Gallego
- María J. Juan Fita
- Pol Servián Vives
- Natàlia Picola
Institutions
- Hospital Universitario La Paz (ES)
- Bellvitge University Hospital (ES)
- Hospital Clínico San Carlos (ES)
- Consorci Sanitari de Terrassa (ES)
- Marqués de Valdecilla University Hospital (ES)
- Hospital Universitario Fundación Alcorcón (ES)
- Hospital Universitario 12 De Octubre (ES)
- Fundación Instituto Valenciano de Oncología (ES)
- Péterfy Sándor Utcai Kórház-Rendelőintézet és Baleseti Központ (HU)
- Hospital Universitario Príncipe de Asturias (ES)
- Hospital Clínic de Barcelona (ES)
- Federico II University Hospital (IT)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Dipreca (CL)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Universitari de Tortosa Verge de la Cinta (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital Universitario de León (ES)
- Hospital Universitario Infanta Sofía (ES)
- Complejo Asistencial Universitario de Palencia (ES)
- Deleted Institution
Publication Details
- Journal
- European Urology Open Science
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1016/j.euros.2024.10.001
- Citations
- 4
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.68